COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Auto Summaries -
Immunology
Last updated: 2024 Nov 18
Total hit(s): 28062
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Auto Summary
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38501434
Politics and confidence toward the COVID-19 vaccination: Points to be considered.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38709953
Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38696268
Deceptive tactics: Misappropriation of scientific literature by 'Gazeta do Povo' in undermining COVID-19 vaccination efforts.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
38787317
Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
5
38626299
Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
6
38353267
Ethical concerns regarding heterologous COVID-19 vaccine administration.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
7
38593300
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
8
39393042
Comment on: "COVID-19 vaccine hesitancy among the Chinese elderly: A multi-stakeholder qualitative study".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
9
39312724
Comment on "Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
10
39520411
Impact of biologics on the immune response to mRNA COVID-19 vaccination in patients with asthma.
N/A
J Allergy Clin Immunol
2024 Nov 8
8.2
1
11
39520876
Erratum to 'Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study'.
N/A
Int J Infect Dis
2024 Nov 8
3.42
1
12
39515078
Corrigendum to "Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study" [Internation Journal of Infectious Diseases, volume 144 (2024) 107064].
N/A
Int J Infect Dis
2024 Nov 7
3.42
1
13
39522531
Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC.
N/A
Lancet Infect Dis
2024 Nov 7
21.77
1
14
39503179
Immunity Debt Associated With Increased Immunological Reactions of M. pneumoniae Pneumonia in Children After the COVID-19 Pandemic.
N/A
Pediatr Pulmonol
2024 Nov 6
2.64
1
15
39505718
Antiplatelet treatment, dyslipidemia, cardiac side events during COVID-19 vaccine, antithrombotic treatment with different BMI.
N/A
Eur Heart J Cardiovasc Pharmacother
2024 Nov 6
5.98
1
16
39498690
Chronic ataxic neuropathy, ophthalmoplegia, immunoglobulin M paraprotein, cold agglutinins, and disialosyl antibodies presenting after COVID19 mRNA vaccination.
N/A
Muscle Nerve
2024 Nov 5
2.28
1
17
39501214
Correction: Meningitis after COVID-19 vaccination, a systematic review of case reports and case series.
N/A
BMC Infect Dis
2024 Nov 5
2.58
1
18
39491729
Covid-19 mRNA vaccine allergy.
N/A
J Allergy Clin Immunol
2024 Nov 2
8.2
1
19
39545819
Correction to: Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination.
N/A
Clin Infect Dis
2024 Nov 15
7.71
1
20
39527299
Correction: SARS-CoV-2 booster vaccination does not worsen glycemia in people with type 1 diabetes using insulin pumps: an observational study.
N/A
Acta Diabetol
2024 Nov 11
3
1
21
39432774
Response to Comment on Hsieh et al. COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records. Diabetes Care 2023;46:2193-2200.
N/A
Diabetes Care
2024 Nov 1
13.02
1
22
39432772
Comment on Hsieh et al. COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records. Diabetes Care 2023;46:2193-2200.
N/A
Diabetes Care
2024 Nov 1
13.02
1
23
39442359
[Flu-COVID-19 vaccination: together, but not mixed together].
N/A
Aten Primaria
2024 Nov
0.34
1
24
39310378
COVID-19 vaccine uptake among young adults and influence of asthma.
N/A
J Allergy Clin Immunol Glob
2024 Nov
1
25
39534188
Adverse Events Associated With SARS-CoV-2 Vaccination in Patients With Glomerular Diseases and the Potential Risk of Disease Reactivation.
N/A
Kidney Int Rep
2024 Nov
2.26
1